Diagnosing coronary artery disease in patients with hypertension: A resolved dilemma?

Italian Heart Journal

Volumn 1, Issue 11, 2000, Pages 726-731

  Fragasso, G ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Coronary artery disease; Dobutamine; Exercise test; Hypertension; Myocardial scintigraphy; Stress echocardiography

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE; ERGOMETRINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ANGIOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; EXERCISE ELECTROCARDIOGRAPHY; HEART SCINTISCANNING; HUMAN; HYPERTENSION; PREDICTION; REVIEW; STRESS ECHOCARDIOGRAPHY;

CARDIOTONIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; DIPYRIDAMOLE; DOBUTAMINE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INFANT, NEWBORN; SENSITIVITY AND SPECIFICITY; SYMPATHOMIMETICS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 0033634960     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Relationship of blood pressure, serum cholesterol, smoking habits, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the Pooling Project
2. The influence of hypertension and other haemodynamic factors in atherogenesis
3. The heart in hypertension
4. Coexistence of hypertensive and coronary arterial disease
5. How can we diagnose coronary heart disease in hypertensive patients?
6. False positive stress tests due to undetected left ventricular hypertrophy
7. Thallium-201 stress imaging in hypertensive patients
8. Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography
9. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease
10. A negative thallium (± dipyridamole) stress test excludes significant obstructive epicardial coronary artery disease in hypertensive patients
11. Dipyridamole echocardiography in essential hypertensive patients with chest pain
12. Diagnostic accuracy of dobutamine stress echocardiography for detection of coronary heart disease in hypertensive patients
13. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test
14. Detection of hypertensive left ventricular hypertrophy
15. Alterations in the coronary circulation in hypertrophied ventricles
16. Silent myocardial ischemia in patients with essential hypertension
17. Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy
18. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension
19. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy
20. Reduction of coronary reserve a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries
21. Hypertension and left ventricular hypertrophy are associated with impaired endothelium mediated relaxation in human coronary resistance vessels
22. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy
23. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography
24. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension
25. The role of coronary microvascular dysfunction in the genesis of cardiovascular diseases
26. Sequence and magnitude of ventricular volume changes in painful and painless myocardial ischemia
27. Stress echocardiography. From pathophysiological toy to diagnostic tool
28. Limitations of dipyridamole-echocardiography in effort angina pectoris
29. Stress echocardiography, comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease
30. Dobutamine development of a new catecholamine to selectively increase cardiac contractility
31. Echocardiographic detection of coronary artery disease during dobutamine infusion
32. Dobutamine stress echocardiography for detection and assessment of coronary artery disease
33. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
34. The comparable diagnostic accuracy of dobutamine and dipyridamole stress echocardiography a meta-analysis
35. Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy
36. Pharmacological stress with dipyridamole: How lazy can one be?
37. Dipyridamole is superior to dobutamine for thallium stress imaging: A randomised cross-over study
38. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography
39. Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine and dipyridamole tests
40. Selection of the optimal non exercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion: Comparison of dobutamine and adenosine using echocardiography and 99m Tc-MIBI single photon emission tomography
41. Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease
42. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation
43. Early impairment of coronary flow reserve in young men with borderline hypertension
44. Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment
45. Assessing the coronary circulation in hypertension